tiprankstipranks
Trending News
More News >

Larimar Therapeutics sees cash runway into 2Q26

As of March 31, 2025, the Company had cash, cash equivalents and marketable securities totaling $157.5 million.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1